Literature DB >> 2456490

Reactivity with the peripheral myelin glycoprotein P0 in serum from patients with monoclonal IgM gammopathy and polyneuropathy.

E Bollensen1, A J Steck, M Schachner.   

Abstract

The major glycoprotein P0 from human and bovine peripheral nerves carries the L2/HNK-1 and L3 carbohydrate epitopes and is recognized by serum from patients with IgM gammopathy and polyneuropathy. Only serum from patients with reactivity toward the myelin-associated glycoprotein (MAG) was reactive with P0, while serum that did not react with MAG also did not recognize P0. Furthermore, the neural adhesion molecules L1, N-CAM, and J1 were also recognized by the serum that reacted with MAG, while the L3 carbohydrate-carrying cell adhesion molecule AMOG was not recognized. These observations indicate a restricted specificity in carbohydrate reactivity of IgM paraproteins and implicate yet another and, for the first time, peripheral myelin-specific glycoprotein in the pathogenesis of demyelinating neuropathy.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2456490     DOI: 10.1212/wnl.38.8.1266

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  17 in total

Review 1.  Relationship between autoantibody specificities and peripheral nervous system involvements.

Authors:  M O Jauberteau-Marchan
Journal:  Clin Rev Allergy Immunol       Date:  2000-08       Impact factor: 8.667

Review 2.  Immunological mechanisms in paraneoplastic peripheral neuropathy.

Authors:  J C Antoine
Journal:  Clin Rev Allergy Immunol       Date:  2000-08       Impact factor: 8.667

3.  A randomised clinical trial comparing interferon-alpha and intravenous immunoglobulin in polyneuropathy associated with monoclonal IgM. The IgM-associated Polyneuropathy Study Group.

Authors:  X Mariette; C Chastang; P Clavelou; J P Louboutin; J M Leger; J C Brouet
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-07       Impact factor: 10.154

4.  The neural cell adhesion molecule N-CAM enhances L1-dependent cell-cell interactions.

Authors:  G Kadmon; A Kowitz; P Altevogt; M Schachner
Journal:  J Cell Biol       Date:  1990-01       Impact factor: 10.539

Review 5.  The role of glycoproteins in neural development function, and disease.

Authors:  K C Breen; C M Coughlan; F D Hayes
Journal:  Mol Neurobiol       Date:  1998-04       Impact factor: 5.590

6.  Identification of monoclonal antibody At5 as a new member of HNK-1 antibody family: the reactivity with myelin-associated glycoprotein and with two brain-specific proteoglycans, phosphacan and neurocan.

Authors:  A A Preobrazhensky; A Oohira; G Maier; A S Voronina; T S Vovk; V M Barabanov
Journal:  Neurochem Res       Date:  1997-02       Impact factor: 3.996

7.  Polyneuropathy associated with IgM monoclonal gammopathy. Immunological and pathological study in 31 patients.

Authors:  A Vital; C Vital; J Julien; A Baquey; A J Steck
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

Review 8.  Antiglycolipid antibodies in peripheral neuropathy: fact or fiction?

Authors:  H J Willison
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-11       Impact factor: 10.154

9.  Charcot-Marie-Tooth disease: a novel Tyr145Ser mutation in the myelin protein zero (MPZ, P0) gene causes different phenotypes in homozygous and heterozygous carriers within one family.

Authors:  Alejandro Leal; Corinna Berghoff; Martin Berghoff; Gerardo Del Valle; Carlos Contreras; Olga Montoya; Erick Hernández; Ramiro Barrantes; Ursula Schlötzer-Schrehardt; Bernhard Neundörfer; André Reis; Bernd Rautenstrauss; Dieter Heuss
Journal:  Neurogenetics       Date:  2003-07-05       Impact factor: 2.660

10.  Serum IgG antibodies to P0 dimer and 35 kDa P0 related protein in neuropathy associated with monoclonal gammopathy.

Authors:  A Favereaux; A Lagueny; A Vital; J-M Schmitter; S Chaignepain; X Ferrer; I Labatut-Cazabat; C Vital; K G Petry
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-09       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.